×

Dr. Sandeep K S

Dr. Sandeep K S

Dr. Sandeep K S

QualificationMBBS, MD,DNB

Specialities Medical OncologyRadiation Oncology

Locations HCG Cancer Center - HubliHCG Cancer Center - Gulbarga
Book an Appointment

Introduction

Dr. Sandeep K. S. is an adept consultant in medical oncology, practicing at HCG Cancer Centre, a leading cancer hospital in Kalaburagi. He specializes in managing various types of cancer through systemic therapies, namely chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapy. After completing his MBBS, he obtained his MD from MS Ramaiah Medical College, followed by a Diplomate of the National Board (DNB) in Medical Oncology. He has also completed his European Society of Medical Oncology (ESMO) certification.

 

He has completed his Certification Course in Essentials of Palliative Care (CCEPC), reflecting his holistic approach to patient care and his understanding of the importance of addressing the diverse needs of cancer patients.

Area of Expertise

●        Dr. Sandeep K.S. is a skilled medical oncologist, and his primary interest lies in the management of breast cancer, lung cancer, head and neck cancers, and gynecological cancers through systemic therapies.

●        His secondary interest lies in the treatment and management of lymphoma, multiple myeloma, chronic myeloid leukemia, and gastrointestinal cancers.

●        Dr. Sandeep, as a leading medical oncologist in Kalaburagi, is particularly passionate about incorporating cutting-edge therapies and personalized treatment approaches to optimize patient outcomes and quality of life.

●        In addition to his clinical practice, Dr. Sandeep is actively involved in research and academics.

●        He has various publications and presentations in national and international journals, which underscores his dedication to keeping himself abreast of the latest innovations and advancements in the field of cancer care.

Research & Publications

●        Clinicopathological Profile, Treatment Response and Survival of Cervical Cancer Patients from a Tertiary Cancer Centre in North Karnataka - May 2022 - Asian Pacific Journal of Cancer Care, 7(2):213-217

●        Molecular Marker as a Prognostic Indicator in Head and Neck Cancer Patients - IASO Nov 2018.

●        Tolerance of Radical Radiation in Elderly Head and Neck Cancer Patients - IJSO Nov 2019.

●        Exceptional Responders to Immunotherapy: A Rare Case of Post-HSCT Relapse Responding to Nivolumab – IJHOSCR, April 2019.

●        Intraconal Metastasis Leading to Diagnosis of Hepatocellular CarcinomaMiddle East Journal of Digestive Diseases, Jan 2020

●        Clinical Outcomes and Safety Study of Cdk4/6 Inhibitors in Hormone-Positive Metastatic Breast Cancer - A Real World Tertiary Cancer Centre Experience - 2024 IJC.

●        Clinical Benefit and Safety of Palbociclib in Hormone-Positive Breast Cancer with Visceral Metastasis - Real-World Experience From a Tertiary Cancer Centre - 2024 IJMPO.

Awards & Accolades

●        Dr. Sandeep is the recipient of the best oral presentation award during the ICC 2023 event.

Other Doctors